The structure of the TGF-β latency associated peptide region determines the ability of the proprotein convertase furin to cleave TGF-βs

Journal of Cellular Biochemistry

Volumn 103, Issue 1, 2008, Pages 311-320

  Kusakabe, Makoto ^a   Cheong, Pak Leng ^a   Nikfar, Reza ^a   McLennan, Ian S ^a   Koishi, Kyoko ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

c myc epitope; Furin; Latency associated peptide; Molecular tagging; TGF beta2

Indexed keywords

ENZYME; EPITOPE; FURIN; LATENCY ASSOCIATED PEPTIDE; PROTEIN PRECURSOR; SUBTILISIN LIKE PREPROTEIN CONVERTASE; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; IMMUNOCYTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; RAT; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CRICETINAE; FURIN; MICE; MOLECULAR SEQUENCE DATA; RATS; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

EID: 38149044017     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21407     Document Type: Article

References (39)

1. Annes JP, Munger JS, Rifkin DB. 2003. Making sense of latent TGFbeta activation. J Cell Sci 116:217-224.
2. Baillie R, Coombes RC, Smith J. 1996. Multiple forms of TGF-beta 1 in breast tissues: A biologically active form of the small latent complex of TGF-beta 1. Eur J Cancer 32A:1566-1573.
3. Blobe GC, Schiemann WP, Lodish HF. 2000. Role of transforming growth factor beta in human disease. N Engl J Med 342:1350-1358.
4. Chao MV, Bothwell M. 2002. Neurotrophins: To cleave or not to cleave. Neuron 33:9-12.
5. Cordeiro MF, Bhattacharya SS, Schultz GS, Khaw PT. 2000. TGF-beta1, -beta2, and -beta3 in vitro: Biphasic effects on Tenon's fibroblast contraction, proliferation, and migration. Invest Ophthalmol Vis Sci 41:756-763.
6. Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R. 1995. Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem 270:10618-10624.
7. Dubois CM, Blanchette F, Laprise MH, Leduc R, Grondin F, Seidah NG. 2001. Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme. Am J Pathol 158:305-316.
8. Dufour EK, Denault JB, Bissonnette L, Hopkins PC, Lavigne P, Leduc R. 2001. The contribution of arginine residues within the P6-P1 region of alpha 1-antitrypsin to its reaction with furin. J Biol Chem 276:38971-38979.
9. Erbas H, Lennard TW, Lai LC. 1999. Latent forms of transforming growth factor-beta 2 (TGF-beta 2) in breast cyst fluid. Anticancer Res 19:3077-3082.
10. Evan GI, Lewis GK, Ramsay G, Bishop JM. 1985. Isolation of monoclonal antibodies specific for human c-myc protooncogene product. Mol Cell Biol 5:3610-3616.
11. Gottanka J, Chan D, Eichhorn M, Lutjen-Drecoll E, Ethier CR. 2004. Effects of TGF-beta2 in perfused human eyes. Invest Ophthalmol Vis Sci 45:153-158.
12. Hosaka M, Nagahama M, Kim WS, Watanabe T, Hatsuzawa K, Ikemizu J, Murakami K, Nakayama K. 1991. Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway. J Biol Chem 266:12127-12130.
13. Hyytiainen M, Penttinen C, Keski-Oja J. 2004. Latent TGF-beta binding proteins: Extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 41:233-264.
14. Kingsley DM. 1994. The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146.
15. Koishi K, Dalzell KG, McLennan IS. 2000. The expression and structure of TGF-beta2 transcripts in rat muscles. Biochim Biophys Acta 1492:311-319.
16. Kulkarni AB, Thyagarajan T, Letterio JJ. 2002. Function of cytokines within the TGF-beta superfamily as determined from transgenic and gene knockout studies in mice. Curr Mol Med 2:303-327.
17. Lazure C, Gauthier D, Jean F, Boudreault A, Seidah NG, Bennett HP, Hendy GN. 1998. In vitro cleavage of internally quenched fluorogenic human proparathyroid hormone and proparathyroid-related peptide substrates by furin. Generation of a potent inhibitor. J Biol Chem 273:8572-8580.
18. Lee R, Kermani P, Teng KK, Hempstead BL. 2001. Regulation of cell survival by secreted proneurotrophins. Science 294:1945-1948.
19. Leitlein J, Aulwurm S, Waltereit R, Naumann U, Wagenknecht B, Garten W, Weller M, Platten M. 2001. Processing of immunosuppressive pro-TGF-beta 1,2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases. J Immunol 166:7238-7243.
20. Lioubin MN, Madisen L, Roth RA, Purchio AF. 1991. Characterization of latent transforming growth factor-beta 2 from monkey kidney cells. Endocrinology 128:2291-2296.
21. Lu B. 2003. Pro-region of neurotrophins: Role in synaptic modulation. Neuron 39:735-738.
22. Madisen L, Lioubin MN, Marquardt H, Purchio AF. 1990. High-level expression of TGF-beta 2 and the TGF-beta 2(414) precursor in Chinese hamster ovary cells. Growth Factors 3:129-138.
23. Makhijani NS, Bischoff DS, Yamaguchi DT. 2005. Regulation of proliferation and migration in retinoic acid treated C3H10T1/2 cells by TGF-beta isoforms. J Cell Physiol 202:304-313.
24. McCormick KM. 2001. TGFbeta2 activation status during cardiac morphogenesis. Dev Dyn 222:17-25.
25. McLennan IS, Koishi K. 2002. The transforming growth factor-betas: Multifaceted regulators of the development and maintenance of skeletal muscles, motoneurons and Schwann cells. Int J Dev Biol 46:559-567.
26. McLennan IS, Koishi K, Zhang M, Murakami N. 1998. The non-synaptic expression of transforming growth factor-beta 2 is neurally regulated and varies between skeletal muscle fibre types. Neuroscience 87:845-853.
27. Miyazono K, Olofsson A, Colosetti P, Heldin CH. 1991. A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J 10:1091-1101.
28. Molloy SS, Bresnahan PA, Leppla SH, Klimpel KR, Thomas G. 1992. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 267:16396-16402.
29. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB. 1997. Latent transforming growth factor-beta: Structural features and mechanisms of activation. Kidney Int 51:1376-1382.
30. Nakayama K. 1997. Furin: A mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 327:625-635.
31. Qian SW, Burmester JK, Tsang MLS, Weatherbee JA, Hinck AP, Ohlsen DJ, Sporn MB, Roberts AB. 1996. Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule. J Biol Chem 271:30656-30662.
32. Roberts AB, Sporn MB. 1990. The transforming growth factor-betas. In: Sporn MB, Roberts AB, editors. Peptide growth factors and their receptors. Berlin, Germany: Springer-Verlag. pp 419-472.
33. Roberts AB, Sporn MB. 1993. Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 8:1-9.
34. Roberts AB, Flanders KC, Heine UI, Jakowlew S, Kondaiah P, Kim SJ, Sporn MB. 1990. Transforming growth factor-beta: Multifunctional regulator of differentiation and development. Philos Trans R Soc Lond B Biol Sci 327:145-154.
35. Rodriguez C, Chen F, Weinberg RA, Lodish HF. 1995. Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors. J Biol Chem 270:15919-15922.
36. Schalken JA, Roebroek AJM, Oomen PPCA, Wagenaar SS, Debruyne FMJ, Bloemers HPJ, Van de Ven WJM. 1987. fur gene expression as a discriminating marker for small cell and nonsmall cell lung carcinomas. J Clin Invest 80:1545-1549.
37. Shapiro J, Sciaky N, Lee J, Bosshart H, Angeletti RH, Bonifacino JS. 1997. Localization of endogenous furin in cultured cell lines. J Histochem Cytochem 45:3-12.
38. Takahashi S, Nakagawa T, Banno T, Watanabe T, Murakami K, Nakayama K. 1995. Localization of furin to the trans-Golgi network and recycling from the cell surface involves Ser and Tyr residues within the cytoplasmic domain. J Biol Chem 270:28397-28401.
39. Wakefield LM, Kondaiah P, Hollands RS, Winokur TS, Sporn MB. 1991. Addition of a C-terminal extension sequence to transforming growth factor-beta 1 interferes with biosynthetic processing and abolishes biological activity. Growth Factors 5:243-253.